MedTrace Logo

Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

NCT03943186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2019-07-10

No results posted yet for this study

Summary

The goal of this non-interventional study is to investigate the safety, efficacy and tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.

Conditions

  • Acute Viral Pharyngitis

Interventions

DEVICE

Ectoin Lozenges Honey Lemon

application of Ectoin Lozenges (EHT02) in accordance with the instructions for use

DEVICE

Hyaluronic Acid/Icelandic moss Lozenges

application of the lozenges in accordance with the instructions for use

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Andreas Bilstein, Dr · CSO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2019-05-13
Completion
2019-05-13

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03943186 on ClinicalTrials.gov